|
 |
 |
|
“OUTCOMES RESEARCH: BRIDGING THE GAP BETWEEN
RESEARCH AND POLICY”
|
|
ISPOR 6TH ANNUAL EUROPEAN CONGRESSPLANNING COMMITTEE
|
|
PLANNING COMMITTEE CO-CHAIRS:
Joan Rovira PhD,
Senior Health Economist (Pharmaceuticals),Health,
Nutrition and Population,The World Bank, Washington, DC, USA
Xavier Badia Llach PhD, Managing Director, Health
Outcomes Research Europe,Barcelona, Spain
PLANNING COMMITTEE MEMBERS:
Dr. Cristina Espinosa,
Project Manager, Novartis
Farmaceutica, Barcelona, Spain
Dr. Fernando García Alonso, Agencia Española del
Medicamento, Ministerio de Sanidad y Consumo, Madrid, Spain
Dr. Juan Gené, Instituto Catalán de la Salud,
Barcelona, Spain
Dr. Antonio Esteve, Esteve Laboratorios, Barcelona,
Spain
Dr. Carlos Marínez, Johnson & Johnson, Barcelona,
Spain
José Antonio Sacristán MD, Clinical Research
Manager, Lilly S.A., Madrid, Spain
Carlos Gouveia Pinto PhD, Associate Professor,
Instituto Superior de Economia e Gestao, Technical University of Libson,
Lisbon, Portugal
Dr. Lluís Bohigas, Ministry of Health, Spain
Dr. Xavier Bonfill, Iberoamerican Cocharane Center,
Barcelona, Spain
RESEARCH REVIEW COMMITTEE CHAIR:
Paul Kind Mphil,
Senior Research Fellow, Centre
for Health Economics, University of York, York, United Kingdom
WORKSHOP REVIEW COMMITTEE & ISSUES PANELS CO-CHAIRS:
Jens Grueger PhD,
Head of Health Economics
Department,Novartis Pharmaceuticals AG, Basel,Switzerland
Ulf Persson PhL, Research Director, The Institute
for Health Economics, Lund, Sweden
|
|
Committee Dear Colleagues:
We are delighted to welcome you to Barcelona and this ISPOR 6th Annual
European Congress. We have put together the programme under the title
‘Bringing the Gap Between Research & Policy’.
In order to go a step further in the relation between outcomes research and
decision-making, we have planned 3 Plenary Sessions around hot topics that
are nowadays driving the debate in Europe. The first Plenary Session is the
utility of outcomes research in decentralised systems, according to the
trend of decentralisation we are currently witnessing in some large European
countries. The second Plenary Session focuses on the benefits and risks for
the diversity of agents of direct to consumer information and advertisement.
In light of the controversy opened at the European Parliament and Commission
of the European Union, this session will address whether to first pilot with
3 diseases and then decide on the liberalisation of information from
pharmaceutical companies to patients. The third Plenary Session is a classic
that remains unsolved and aims at analysing the impact of outcomes research
in real clinical practice.
Our moderators and speakers are recognised nationally and internationally as
experts in their fields, which include the political and governmental
decision-making perspective, the industry perspective, and the academic or
research perspective.
On Sunday, we will have workshop presentations around methodology in
pharmacoeconomics, outcomes research, patient reported outcomes and health
policy, followed by the Exhibitors’ Open House Reception. Monday evening, we
will have the traditional wine & cheese reception. Contributed workshop
presentations will close this 6th Congress on Tuesday evening.
We would like to sincerely thank all the participants who have contributed
with their presentations to the scientific quality of this congress. We have
also appreciated the contribution of the members of the Planning Committee,
the Research Review Committee and the Workshop Review Committee and Issues
Panels. We would finally like to thank Marilyn Dix Smith and her ISPOR team
as well as Marta Oliva for their commitment and support to the excellent
organization of the meeting.
We hope that you will enjoy this Congress’s Program and discussions as well
as the beautiful city of Barcelona during the ISPOR Sixth Annual European
Congress.
Yours sincerely,

Xavier Badia, MD, PhD
Managing Director
Health Outcomes Research
Europe Group Barcelona, Spain Congress Co-Chair |

Joan Rovira, PhD
Senior Health Economist
The World Bank
Washington, DC, USA
Congress
Co-Chair |
|
|
>>Back to
6th European Congress Main Page |
|